Analyst Upgrades – Illumina (NASDAQ:ILMN) Stock Gets Upgraded By Leerink Swann from Market Perform to Outperform

39

Analyst Ratings For Illumina (NASDAQ:ILMN)

Today, Illumina (NASDAQ:ILMN) stock received an upgrade by Leerink Swann from Market Perform to Outperform.

There are 3 sell ratings, 11 hold ratings, 9 buy ratings on the stock.

The current consensus rating on Illumina (NASDAQ:ILMN) is Hold (Score: 2.26) with a consensus target price of $153.02 per share, a potential 4.61% downside.

Some recent analyst ratings include

  • 3/20/2017-Leerink Swann Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
  • 3/19/2017-BTIG Research Reiterated Rating of Hold.
  • 2/27/2017-Evercore ISI Upgrade from a “Hold ” rating to a ” Buy” rating.
  • 2/21/2017-Canaccord Genuity Reiterated Rating of Hold.
  • 2/1/2017-Cantor Fitzgerald Reiterated Rating of Neutral.
  • 1/18/2017-Deutsche Bank AG Reiterated Rating of Hold.
  • 1/12/2017-Robert W. Baird Reiterated Rating of Neutral.

Dividend information for Illumina (NASDAQ:ILMN)

.
Recent Insider Trading Activity For Illumina (NASDAQ:ILMN)
Illumina (NASDAQ:ILMN) has insider ownership of 1.60% and institutional ownership of 92.79%.

  • On 2/17/2017 Daniel Bradbury, Director, sold 600 with an average share price of $162.80 per share and the total transaction amounting to $97,680.00. View SEC Filing
  • On 2/13/2017 Omead Ostadan, EVP, sold 2,173 with an average share price of $163.10 per share and the total transaction amounting to $354,416.30. View SEC Filing
  • On 2/8/2017 A Blaine Bowman, Director, sold 3,000 with an average share price of $162.74 per share and the total transaction amounting to $488,220.00. View SEC Filing
  • On 2/6/2017 Charles Dadswell, SVP, sold 572 with an average share price of $161.26 per share and the total transaction amounting to $92,240.72. View SEC Filing
  • On 1/30/2017 Omead Ostadan, EVP, sold 259 with an average share price of $160.90 per share and the total transaction amounting to $41,673.10. View SEC Filing
  • On 1/19/2017 Omead Ostadan, EVP, sold 2,378 with an average share price of $160.06 per share and the total transaction amounting to $380,622.68. View SEC Filing
  • On 1/11/2017 A Blaine Bowman, Director, sold 3,000 with an average share price of $162.89 per share and the total transaction amounting to $488,670.00. View SEC Filing

About Illumina (NASDAQ:ILMN)
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company’s portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.

Recent Trading Activity for Illumina (NASDAQ:ILMN)
Shares of Illumina closed the previous trading session at 160.42 up +0.96 0.60% with 1,917,751 shares trading hands.

An ad to help with our costs